Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL

Despite improved survival in the Rituximab (R) era, a considerable number of patients with diffuse large B-cell lymphoma (DLBCL) ultimately die from the disease. Functional imaging using [(18)F]fluorodeoxyglucose-PET is suggested for assessment of residual viable tumor very early during treatment bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrmann, Ken, Buck, Andreas K., Schuster, Tibor, Abbrederis, Kathrin, Blümel, Christina, Santi, Ivan, Rudelius, Martina, Wester, Hans-Jürgen, Peschel, Christian, Schwaiger, Markus, Dechow, Tobias, Keller, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147305/
https://www.ncbi.nlm.nih.gov/pubmed/24979177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147305/
https://www.ncbi.nlm.nih.gov/pubmed/24979177

Ejemplares similares